The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Activation of virus replication after vaccination of HIV-1-infected individuals.
Open accessAbstract
Little is known about the factors that govern the level of HIV-1 replication in infected individuals. Recent studies (using potent antiviral drugs) of the kinetics of HIV-1 replication in vivo have demonstrated that steady-state levels of viremia are sustained by continuous rounds of de novo infection and the associated rapid turnover of CD4+ T lymphocytes. However, no information is available concerning the biologic variables that determine the size of the pool of T cells that are susceptible to virus infection or the amount of virus produced from infected cells. Furthermore, it is not known whether all CD4+ T lymphocytes are equally susceptible to HIV-1 infection at a given time or whether the infection is focused on cells of a particular state of activation or antigenic specificity. Although HIV-1 replication in culture is known to be greatly facilitated by T cell activation, the ability of specific antigenic stimulation to augment HIV-1 replication in vivo has not been studied. We sought to determine whether vaccination of HIV-1-infected adults leads to activation of virus replication and the targeting of vaccine antigen-responsive T cells for virus infection and destruction. Should T cell activation resulting from exposure to environmental antigens prove to be an important determinant of the steady-state levels of HIV-1 replication in vivo and lead to the preferential loss of specific populations of CD4+ T lymphocytes, it would have significant implications for our understanding of and therapeutic strategies for HIV-1 disease. To begin to address these issues, HIV-1-infected individuals and uninfected controls were studied by measurement of immune responses to influenza antigens and quantitation of virion-associated plasma HIV-1 RNA levels at baseline and at intervals after immunization with the trivalent influenza vaccine. Influenza vaccination resulted in readily demonstrable but transient increases in plasma HIV-1 RNA levels, indicative of activation of viral replication, in HIV-1-infected individuals with preserved ability to immunologically respond to vaccine antigens. Activation of HIV-1 replication by vaccination was more often seen and of greater magnitude in individuals who displayed a T cell proliferative response to vaccine antigens at baseline and in those who mounted a significant serologic response after vaccination. The fold increase in viremia, as well as the rates of increase of HIV-1 in plasma after vaccination and rates of viral decline after peak viremia, were higher in individuals with higher CD4+ T cell counts.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,267
Viral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,260
Structure, Regulation and Function of NF-kappaB
Siebenlist, U., Franzoso, G., & Brown, K. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002201 · Cited by 2,075
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
Coffin, J. M. (1995) · Science · doi:10.1126/science.7824947 · Cited by 1,981
Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., & Fauci, A. S. (1993) · Nature · doi:10.1038/362355a0 · Cited by 1,808
Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., & Chen, I. S. Y. (1990) · Cell · doi:10.1016/0092-8674(90)90802-l · Cited by 1,517
Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K., & Haase, A. T. (1993) · Nature · doi:10.1038/362359a0 · Cited by 1,419
High Levels of HIV-1 in Plasma During All Stages of Infection Determined By Competitive PCR
Piatak, M., Saag, M. S., Yang, L. C., Clark, S. J., Kappes, J. C., Luk, K.-C., Hahn, B. H., Shaw, G. M., & Lifson, J. D. (1993) · Science · doi:10.1126/science.8096089 · Cited by 1,237
Conover, W. J., Johnson, M. E., & Johnson, M. M. (1981) · Technometrics · doi:10.1080/00401706.1981.10487680 · Cited by 1,006
HIV-1 replication is controlled at the level of T cell activation and proviral integration.
Stevenson, M., Stanwick, T. L., Dempsey, M. P., & Lamonica, C. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08274.x · Cited by 800
Multifactorial Nature of Human Immunodeficiency Virus Disease: Implications for Therapy
Fauci, A. S. (1993) · Science · doi:10.1126/science.8235617 · Cited by 776
Human immunodeficiency virus infection of cells arrested in the cell cycle.
Lewis, P., Hensel, M., & Emerman, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05376.x · Cited by 531
Antigen-independent activation of naive and memory resting T cells by a cytokine combination.
Unutmaz, D., Pileri, P., & Abrignani, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1159 · Cited by 524
Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection
Pape, J. W., Jean, S. S., Ho, J. L., Hafner, A., & Johnson, W. D. (1993) · The Lancet · doi:10.1016/0140-6736(93)91817-6 · Cited by 441
Kovacs, J. A., Baseler, M., Dewar, R. J., Vogel, S., Davey, R. T., Falloon, J., Polis, M. A., Walker, R. E., Stevens, R., Salzman, N. P., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503023320904 · Cited by 425
Schnittman, S. M., Lane, H. C., Greenhouse, J., Justement, J. S., Baseler, M., & Fauci, A. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6058 · Cited by 425
Couch, R. B., & Kasel, J. A. (1983) · Annual Review of Microbiology · doi:10.1146/annurev.mi.37.100183.002525 · Cited by 424
Pneumococcal Disease during HIV Infection: Epidemiologic, Clinical, and Immunologic Perspectives
Janoff, E. N., Breiman, R. F., Daley, C. L., & Hopewell, P. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-314 · Cited by 323
Piatak, M., Luk, K., Williams, B., et al. (1993) · PubMed · Cited by 314
O'Brien, W., Grovit-Ferbas, K., Namazi, A., Ovcak-Derzic, S., Wang, H., Park, J., Yeramian, C., Mao, S., & Zack, J. (1995) · Blood · doi:10.1182/blood.v86.3.1082.1082 · Cited by 304
Hadler, S. C., Judson, F. N., O'Malley, P. M., Altman, N. L., Penley, K., Buchbinder, S., Schable, C. A., Coleman, P. J., Ostrow, D. N., & Francis, D. R. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.3.454 · Cited by 260
Pachl, C. A., Todd, J. A., Kern, D. G., Sheridan, P. J., Fong, S.-J., Stempien, M. M., Hoo, B., Besemer, D. J., Yeghiazarian, T., Irvine, B. D., et al. (1995) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199504120-00003 · Cited by 232
Clements, M. L., & Murphy, B. R. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.23.1.66-72.1986 · Cited by 230
Kroon, F. P., van Dissel, J. T., de Jong, J. C., & van Furth, R. (1994) · AIDS · doi:10.1097/00002030-199404000-00008 · Cited by 230
Grossman, Z., & Paul, W. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10365 · Cited by 226
Cheynier, R., Henrichwark, S., Hadida, F., Pelletier, E., Oksenhendler, E., Autran, B., & Wain-Hobson, S. (1994) · Cell · doi:10.1016/0092-8674(94)90417-0 · Cited by 204
Dewar, R. L., Highbarger, H. C., Sarmiento, M. D., Todd, J. A., Vasudevachari, M. B., Davey, R. T., Kovacs, J. A., Salzman, N. P., Lane, H. C., & Urdea, M. S. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1172 · Cited by 166
Early T-helper cell defects in HIV infection
Shearer, G. M., & Clerici, M. (1991) · AIDS · doi:10.1097/00002030-199103000-00001 · Cited by 164
Cox, R. J., Brokstad, K. A., Zuckerman, M. A., Wood, J., Haaheim, L. R., & OXFORD, J. S. (1994) · Vaccine · doi:10.1016/0264-410x(94)90334-4 · Cited by 153
Parenteral Influenza Vaccination Induces A Rapid Systemic And Local Immune Response
Brokstad, K. A., Cox, R. J., Olofsson, J. S., Jonsson, R., & Haaheim, L. R. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.198 · Cited by 145
Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia.
Carding, S. R., Allan, W., McMickle, A., & Doherty, P. C. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.2.475 · Cited by 145
The Influence of HIV Infection on Antibody Responses to a Two-Dose Regimen of Influenza Vaccine
Miotti, P., Nelson, K. E., Dallabetta, G. A., Farzadegan, H., Margolick, J., & Clements, M. L. (1989) · JAMA · doi:10.1001/jama.1989.03430060075029 · Cited by 140
Nelson, K. E., Clements, M. L., Miotti, P., Cohn, S., & Polk, B. F. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-5-383 · Cited by 121
Influenza and pneumococcal vaccination of HIV-infected patients: A policy analysis
Rose, D. N., Schechter, C. B., & Sacks, H. S. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90178-r · Cited by 70
Weiß, P. J., Wallace, M. R., Oldfield, E. C., O'Brien, J., & Janoff, E. N. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.5.1217 · Cited by 68
Preventive Health Care for Adults With HIV Infection
Jewett, J. F. (1993) · JAMA · doi:10.1001/jama.1993.03500090080037 · Cited by 51
Haemophilus influenzae and viruses 100 years later: From influenza to human immunodeficiency virus
Murphy, T. F. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90773-5 · Cited by 5
Cited by
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,977
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,033
Host factors and the pathogenesis of HIV-induced disease
Fauci, A. S. (1996) · Nature · doi:10.1038/384529a0 · Cited by 829
Metadata
- Authors
- Staprans, S. I., Hamilton, B. L., Follansbee, S. E., Elbeik, T., Barbosa, P., Grant, R. M., & Feinberg, M. B.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1995-12-01
- Volume
- 182
- Issue
- 6
- Pages
- 1727-1737
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1993190635
- Cited by
- 318
- References
- 38
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.